By docking with the C-terminal segment of STAT3, CCAT5 counters SHP-1-mediated dephosphorylation at tyrosine 705, thus promoting the nuclear translocation and transactivation of STAT3 and facilitating the progression of GC. Here, STAT3 is linked to gastric cancer.